heartburn from glp 1 with glp-1 Support for Patients on GLP-1 Medications Experiencing heartburn while on GLP-1s?
Description
Danuglipron (dosed twice daily) and orforglipron (once daily) continue in clinical trials, while the clinical development of lotiglipron (once daily) was recently stopped due to elevated transaminase liver enzymes
certain conditions (thyroid disease, cardiovascular complications, pregnancy) may disqualify patients
Cagrilintide: How much weight can you lose
Focus on the Positives While weight loss is a primary goal, shift focus beyond just the number on the scale
Brain insulin resistance: focus on insulin receptor-mitochondria interactions
GLP-1s are also associated with a low but increased risk of pancreatitis
